Skip to main content
NewslettersWatchlist

Medipharm Labs Corp(LABS-T)
TSX

Today's Change
Real-Time Last Update
Day Low0.0650
Day High0.0700
Open:0.0700
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
PR Newswire
MediPharm Labs Reports Third Quarter Results
Baystreet
Stocks in play: MediPharm Labs Corp.
Newswire.ca
MediPharm Labs Sets Date to Report Third Quarter 2024 Financial Results
Newswire.ca
MediPharm Labs Announces Departure of President and Co-Founder Keith Strachan
PR Newswire
MediPharm Labs Announces Departure of President and Co-Founder Keith Strachan
Baystreet
Stocks in play: MediPharm Labs Corp.
Newswire.ca
MediPharm Labs Announces $2.1M Debt Repayment
Baystreet
Stocks in play: MediPharm Labs Corp.
Newswire.ca
MediPharm Labs Reports Second Quarter Results Closing in on Positive Adjusted EBITDA(1) as Gross Profit Continues to Improve
Newswire.ca
/R E P E A T -- MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results/
Newswire.ca
MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results
Baystreet
Stocks in play: MediPharm Labs Corp.
Newswire.ca
MediPharm Labs Announces Voting Results From the 2024 Annual Meeting of Shareholders
Baystreet
Stocks in play: MediPharm Labs Corp.
Newswire.ca
MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols
AI-generated - The Globe and Mail
MediPharm Labs: Top 10 Undervalued Drug Manufacturers Industry Stocks (LABS)
Newswire.ca
MediPharm Labs Reports First Quarter Results
Newswire.ca
MediPharm Labs Sets Date to Report First Quarter 2024 Financial Results
Newswire.ca
MediPharm Labs Provides Conference Call Recording Details
Newswire.ca
MediPharm Labs Reports Fourth Quarter and Full Year Results
Baystreet
Stocks in play: MediPharm Labs Corp.
Newswire.ca
MediPharm Labs Provides Update on German Cannabis Legalization

Profile

MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis flower, extracts, and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically the company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.